Filing metadata

Accession number
0000950170-24-002291
Form type
Form 4
Filer
Fusion Pharmaceuticals Inc.
CIK
CIK 1805890
Filed
Jan 05, 2024
Reporting period
Jan 04, 2024
Description
Insider transaction

Explore SEC Filings Hub